Limb-Girdle Video Assessment

NCT ID: NCT05528757

Last Updated: 2023-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-20

Study Completion Date

2022-11-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop a new remote-based video assessment outcome measure for Limb-Girdle Muscular Dystrophy (LGMD) trials. The overall objectives for this study are: 1. Identify domains and tasks meaningful to participants with a Limb-Girdle Muscular Dystrophy (LGMD) for development of the LGVA, including considerations for subtype heterogeneity and functional subgroup branching; 2. Determine the feasibility and reliability of the LGVA with test-retest of the LGVA Video Capture Manual; 3. Assess and refine the LGVA Video Capture Manual to ensure standardization and incorporate feedback from participants; 4. Collect source material videos using the LGVA Video Capture Manual to support the development of scorecards for the LGVA.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to gain insight from people living with an LGMD and gather source material videos to develop and test Limb-Girdle Video Assessment (LGVA), a new outcome measure designed to assess changes in functional abilities of participants in LGMDs clinical trials. The LGVA is being designed as a remote video capture to assess nuanced changes in compensatory movement patterns over time. This study involves two stages. In the concept elicitation stage, the tasks for the LGVA Video Capture Manual will be finalized based on feedback from participants living with an LGMD 2A, 2B, or 2I in various stages of disease progression. After finalizing the LGVA Video Capture Manual, source material videos will be collected to evaluate the feasibility and appropriateness of the LGVA tasks, standardize capture procedures, and inform the development of scorecards for the LGVA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Limb-Girdle Muscular Dystrophy ; Subtypes 2A, 2B, and 2I

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Limb-Girdle Muscular Dystrophy Outcome Measure Development Video Captures Remote Assessment Concept Elicitation Feasibility Testing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LGMDs Patients

Patients with a genetically confirmed diagnosis of a LGMD subtype 2A, 2B, or 2I

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person with confirmed diagnosis of an LGMD 2A, 2B, or 2I
* ≥14 years of age at the timing of consent (if age 14 - 17, consent from the parent/ legal guardian is also needed)
* Able to read, speak, and understand English
* Residing in the USA
* Willing and able to complete an electronic survey, which includes questions about personal characteristics and medical history as well as review of tasks
* Willing and able to discuss their experiences as a person living with an LGMD in a group setting
* Willing and able to complete 2 rounds of video capture following instructions in the LGVA Video Capture Manual in a 30-day period
* Willing and able to complete an exit interview to discuss their experiences capturing and recording videos with the LGVA Video Capture Manual
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coalition to Cure Calpain 3 (C3)

UNKNOWN

Sponsor Role collaborator

Jain Foundation

OTHER

Sponsor Role collaborator

The Emmes Company, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lauren Carroll

Role: STUDY_DIRECTOR

Casimir

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Casimir

Kingston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAS-CAS008-01

Identifier Type: -

Identifier Source: org_study_id